TYSABRI® (Natalizumab) is a prescription medicine used to treat adults with relapsing forms of Multiple Sclerosis.
TYSABRI® is manufactured by Biogen.
Administration and Dosage:
Administration of TYSABRI® is by intravenous infusion every 4 weeks.
Common Side Effects:
The more common side effects of TYSABRI® include herpes infections, liver damage, allergic reactions, weakened immune system, and low platelet counts.
Ready to Schedule an Appointment?
Please CLICK HERE to get started.
TYSABRI® is indicated to treat:
- Multiple Sclerosis